tiprankstipranks
Neurometrix (NURO)
NASDAQ:NURO
US Market

Neurometrix (NURO) Stock Price & Analysis

305 Followers

NURO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.70 - $8.16
Previous Close$3.71
Volume20.28K
Average Volume (3M)17.35K
Market Cap
$7.46M
Enterprise Value-$10.29M
Total Cash (Recent Filing)$18.00M
Total Debt (Recent Filing)$240.88K
Price to Earnings (P/E)
Beta1.13
Jul 18, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.97
Shares Outstanding2,011,485
10 Day Avg. Volume8,020
30 Day Avg. Volume17,348
Standard Deviation0.51
R-Squared0.05
Alpha-0.00540
Financial Highlights & Ratios
Price to Book (P/B)0.37
Price to Sales (P/S)1.26
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-2.25
Enterprise Value/Gross Profit-2.61
Enterprise Value/Ebitda-8.98
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

NURO FAQ

What was Neurometrix’s price range in the past 12 months?
Neurometrix lowest stock price was $2.70 and its highest was $8.16 in the past 12 months.
    What is Neurometrix’s market cap?
    Currently, no data Available
    When is Neurometrix’s upcoming earnings report date?
    Neurometrix’s upcoming earnings report date is Jul 18, 2024 which is in 25 days.
      How were Neurometrix’s earnings last quarter?
      Neurometrix released its earnings results on May 15, 2024. The company reported -$1.672 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.672.
        Is Neurometrix overvalued?
        According to Wall Street analysts Neurometrix’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Neurometrix pay dividends?
          Neurometrix does not currently pay dividends.
          What is Neurometrix’s EPS estimate?
          Neurometrix’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Neurometrix have?
          Neurometrix has 2,011,485 shares outstanding.
            What happened to Neurometrix’s price movement after its last earnings report?
            Neurometrix reported an EPS of -$1.672 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.148%.
              Which hedge fund is a major shareholder of Neurometrix?
              Currently, no hedge funds are holding shares in NURO
              ---

              Neurometrix Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -55.40%
              12-Months-Change

              Fundamentals

              Return on Equity
              -39.17%
              Trailing 12-Months
              Asset Growth
              -12.48%
              Trailing 12-Months

              Company Description

              Neurometrix

              NeuroMetrix, Inc. is a healthcare company, which engages in the research, development, and trade of medical equipment and consumables. It offers an over-the-counter wearable therapeutic device for chronic pain, the Quell Health Cloud, DPNCheck, and pain management devices to treat chronic pain, nerve diseases, and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
              ---

              NURO Earnings Call

              Q4 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              BioCryst
              Fate Therapeutics
              Arrowhead Pharmaceuticals
              Sorrento Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis